StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

4-Hydroxyhexenal

HCID 5283314
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
109710-37-4
Standard-SMILES
CCC(O)/C=C/C=O
InChIKey
JYTUBIHWMKQZRB-ONEGZZNKSA-N
Summenformel
C6H10O2
Durchschnittliche Molmasse
114,14 g/mol
Monoisotopische Masse
114,06807956

Überblick

4-hydroxyhexenal is a monounsaturated fatty aldehyde.

Namen und Bezeichner

Bevorzugter Name
4-Hydroxyhexenal
IUPAC
(E)-4-hydroxyhex-2-enal
Englischer Name
4-hydroxy Hexenal
Summenformel
C6H10O2
Molmasse
114.14

Namen und Synonyme

4-Hydroxyhexenal4-hydroxy-2E-hexenalRefChem:912587109710-37-44-hydroxy Hexenal17427-21-3(E)-4-hydroxyhex-2-enal4-HHE(E)-4-Hydroxy-2-hexenal2-Hexenal, 4-hydroxy-, (2E)-(2E)-4-hydroxyhex-2-enal160708-91-8
Weitere Namen anzeigen
4-hydroxy-2(E)-hexena
CHEMBL5277300(E)-4-HYDROXYHEXENALHexenal, 4-hydroxy-2-HEXENAL, 4-HYDROXY-(2E)-4-hydroxy-2-hexenalCCRIS 9201(E)-4-Hydroxy Hexenal2-Hexenal, 4-hydroxy-, (E)-

Datenbank-Bezeichner

CAS
109710-37-4、17427-08-6、17427-21-3
PubChem CID
5283314
DTXSID
DTXSID701313524
ChEMBL
CHEMBL5277300
ChEBI
CHEBI:180385
Nikkaji
J49.434H、J548.917B

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
0,2
Polarare Oberfläche (TPSA)
37,3 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
3
Schwere Atome
8
Formalladung
0
Komplexität
86,5

Experimentelle und physikochemische Eigenschaften

LipidsFatty Acyls [FA] -> Fatty aldehydes [FA06]

Physikochemische Eigenschaften

Siedepunkt
89 · 89-90 °C(Press: 2 Torr)
Dichte
0.98 · 0.980±0.06 g/cm3(Predicted)
storage temp.
-80 °C · Store at -80°C
Löslichkeit
50 mg/ml; · DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: >50 mg/ml; PBS pH 7.2: >1 mg/ml
pka
13.18 · 13.18±0.20(Predicted)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Toxikologische Informationen

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 Eintrag

Uremic toxins such as 4-Hydroxyhexenall are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

Signs and Symptoms · 1 Eintrag

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.

Verwendung und Herstellung

UsesNaturally produced by the body (endogenous).

Anwendungen

Beschreibung4-hydroxy Hexenal is a lipid peroxidation product derived from oxidized ω-3 fatty acids such as DHA.

Verwenden(E)-4-Hydroxy Hexenal is a 4-hydroxyalkenals that induces genotoxic effects in the micromolar range.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung